OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

TissueScan, Prostate Cancer cDNA Array III

Be the first to review this product
SKU
HPRT303
TissueScan Prostate Cancer Tissue qPCR Array III (5) containing 48 tissues covering four disease stages, BPH and normal tissues
  $1,870.00
In Stock*

Frequently Bought Together (4)

D11-18 Polink-1 HRP Polymer Detection for MOUSE and RABBIT antibodies on human tissue
18 ml
$420.00
D12-6 Polink-1 HRP Polymer Detection for MOUSE antibody on human or animal tissue (non-rodent)
6 ml
$250.00
HP205798 qSTAR qPCR primer pairs against Homo sapiens gene GAPDH 200 reactions
$150.00
MP205604 qSTAR qPCR primer pairs against Mus musculus gene Gapdh 200 reactions
$150.00
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Prostate Cancer cDNA Array III
Clinical Info
Diagnosis Category Prostate Cancer
Tissue Prostate
Shipping Ambient
Description TissueScan Prostate Cancer Tissue qPCR Array III (5) containing 48 tissues covering four disease stages, BPH and normal tissues
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancer
Itsumi, Shiota, Sekino et al
Prostate (2020) 80 (11), 885-894 DOI: 10.1002/pros.24022
Cited by 11
AI Summary: In this study, OriGene products—including the AR expression vector (RC220963) and AR shRNA (TL313598)—were used to manipulate androgen receptor levels in prostate cancer cells, enabling the researchers to assess the impact of candidate compounds and 5-HT5A receptor modulation on AR signaling.
BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions
Yun, Bedolla, Horning et al
Int J Mol Sci (2018) 19 (7) DOI: 10.3390/ijms19072104
AI Summary: OriGene’s Tissue Scan Prostate Cancer Tissue qPCR Panel III was used to assess COBRA1 expression levels in human prostate tumor samples, enabling the study to link COBRA1 expression with tumor grade and prostate cancer progression.
Snippet: Expression of COBRA1 in human prostate tumors: (a) Expression of COBRA1 as assessed by qRT-PCR using the Tissue Scan Prostate Cancer Tissue qPCR Panel III (Origene, Rockville, MD, USA) comprising of low (GS < 7;n = 11) and high (GS ≥ 7;n = 37) GS tumors
FigureFigureFigure
Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide
Shiota, Fujimoto, Higashijima et al
Prostate (2018)
AI Summary: OriGene’s TissueScan Prostate Cancer Tissue qPCR array III (HPRT303) was used to assess MR gene expression in human prostate tissues, contributing to the study’s analysis of mineralocorticoid receptor signaling in enzalutamide resistance.
Snippet: investigate MR gene expression in tissues, TissueScan Prostate Cancer Tissue qPCR array III (HPRT303), which contains first‐strand cDNAs prepared from 48 human prostate tissues including both malignant and healthy controls, was purchased from OriGene Technologies
Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer
Shiota, Itsumi, Takeuchi et al
Endocr. Relat. Cancer (2015) 22 (6), 889-900 DOI: 10.1530/ERC-15-0225
AI Summary: OriGene’s TissueScan Prostate Cancer Tissue qPCR array III (HPRT303) was used in this study to analyze gene expression profiles across malignant and healthy human prostate tissues, facilitating the investigation of EMT and castration resistance mechanisms in prostate cancer.
Snippet: TissueScan Prostate Cancer Tissue qPCR array III (HPRT303), which contains first-strand cDNAs prepared from 48 human prostate tissues, including both malignant and healthy controls, was purchased from OriGene Technologies, Inc. (Rockville, MD, USA). ... Cite SaveSaving
Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells
Kashiwagi, Shiota, Yokomizo et al
Endocr. Relat. Cancer (2013) 20 (3), 431-41 DOI: 10.1530/ERC-12-0344
AI Summary: OriGene’s TissueScan Prostate Cancer Tissue qPCR array III (HPRT303) was used to analyze EP3 (PTGER3) transcript levels in human prostate cancer and normal tissues, helping to demonstrate the role of EP3 in prostate carcinogenesis in this study.
Snippet: Quantitative real-time PCR. Synthesized cDNA was diluted to 1:2 ratio;2.0 μl of the diluted sample was used. TissueScan Prostate Cancer Tissue qPCR array III (HPRT303) was purchased from OriGene (Rockville, MD, USA).
Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer
Kashiwagi, Shiota, Yokomizo et al
Prostate (2012) 72 (7), 741-51 DOI: 10.1002/pros.21478
Cited by 33
AI Summary: OriGene’s TissueScan Prostate Cancer Tissue qPCR array III (HPRT303) was used in this study to analyze PDE4B expression levels across prostate cancer tissue samples, helping to demonstrate the association between PDE4B downregulation and prostate cancer progression.
Snippet: protocol. Quantitative Real-Time PCR. The synthesized cDNA was diluted to a 1:2 ratio, and 2.0 µl of the diluted sample was used. TissueScan Prostate Cancer Tissue qPCR array III (HPRT303) was purchased from OriGene.
Showing 1-6 of 6 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products